Top Story

Modified diphenylcyclopropenone therapy may yield fewer adverse events in alopecia areata

November 10, 2017

A modified protocol for administering diphenylcyclopropenone was associated with an acceptable response and fewer adverse events in patients with alopecia areata, according to recent study results.

The retrospective study included 159 patients who were sensitized with 0.1% diphenylcyclopropenone, and then initiated treatment with 0.01% of the drug. Clinicians then slowly increased the concentration according to patient response and incidence of adverse events.

In the Journals

Adalimumab associated with improvements in nail psoriasis

October 31, 2017
Twenty-six weeks of treatment with adalimumab was associated with improvements in a number of fingernail psoriasis outcomes compared with placebo, according to recent…
Meeting News

Platelet-rich plasma injections efficacious for androgenetic alopecia

October 13, 2017
A monthly schedule of platelet-rich plasma injections was safe and efficacious in patients with androgenetic alopecia and may be preferable to injections administered…
In the Journals

Some children with alopecia should undergo thyroid screening

October 5, 2017
Researchers recommended that children with a medical history of Down syndrome and a personal history of atopy are among a limited group of patients with alopecia areata…
More Headlines »